MEI Pharma (MEIP) Reports Q2 EPS of $0.32

MEI Pharma (NASDAQ: MEIP) reported Q2 EPS of $0.32, versus ($0.15) reported last year. Revenue for the quarter came in at $17.1 million, versus $0 reported last year.

For earnings history and earnings-related data on MEI Pharma (MEIP) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• UBS says bull market has further to run
• Is the global equity rally broadening? UBS weighs in